Department of Surgery (General Thoracic Surgery)

Medicine & Life Sciences

1. Lung Neoplasms 100%
2. Lung 56%
3. Neoplasms 51%
4. Neoplasm Staging 43%
5. Adenocarcinoma of Lung 43%
6. Non-Small Cell Lung Carcinoma 41%
7. Survival 29%
8. Neoplasm Metastasis 27%
9. Segmental Mastectomy 26%
10. Thymoma 20%
11. Databases 17%
12. Adenocarcinoma 17%
13. Glass 16%
14. Recurrence 16%
15. Tomography 16%
16. Lymph Nodes 14%
17. Japan 14%
18. Mutation 13%
19. Thymic epithelial tumor 13%
20. Cryosurgery 12%
21. Metastasectomy 12%
22. Thorax 11%
23. Medical Oncology 11%
24. Therapeutics 10%
25. Malignant Mesothelioma 9%
26. Survival Rate 9%
27. Propensity Score 8%
28. Registries 8%
29. Adenocarcinoma in Situ 8%
30. Clinical Trials 8%
31. Carcinoma 8%
32. Dissection 7%
33. Mesothelioma 7%
34. Margins of Excision 7%
35. Chest Tubes 7%
36. Pneumothorax 7%
37. Lymph Node Excision 6%
38. Lovastatin 6%
39. Colorectal Neoplasms 6%
40. Multicenter Studies 6%
41. Pericardium 6%
42. Safety 6%
43. Tumor Microenvironment 6%
44. Idiopathic Pulmonary Fibrosis 6%
45. Squamous Cell Carcinoma 6%
46. Trachea 6%
47. Myasthenia Gravis 5%
48. Needle Biopsy 5%
49. Carcinoid Tumor 5%
50. Mediastinal Neoplasms 5%
51. Mucinous Adenocarcinoma 5%
52. Bronchi 5%
53. ErbB Receptors 5%
54. Biopsy 5%
55. Adjuvant Chemotherapy 5%
56. Pleura 5%
57. Needles 5%
58. Thymus Neoplasms 5%